Strive Health Achieves HITRUST CSF® Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance
HITRUST CSF Certification validates Strive Health is committed to meeting key regulations and protecting sensitive information
Strive Health, a leader in value-based kidney care, announced its CareMultiplier™ platform has earned Certified status for information security by HITRUST.
HITRUST CSF Certified status demonstrates that the organization’s CareMultiplier™ platform has met key regulations and industry-defined requirements and is appropriately managing risk. This achievement places Strive Health in an elite group of organizations worldwide that have earned this certification. By including federal and state regulations, standards, and frameworks, and incorporating a risk-based approach, the HITRUST CSF helps organizations address these challenges through a comprehensive and flexible framework of prescriptive and scalable security controls.
“Organizations and their patients trust Strive Health keep information secure and meet complex compliance and privacy requirements that include technical and process elements such as NIST, ISO, and COBIT,” said Masoud Nourmohammadi, CTO at Strive Health. “We are pleased to demonstrate our dedication to the highest standards for protecting sensitive data and information by achieving HITRUST CSF Certification.”
“In today’s ever-changing threat landscape, HITRUST is continually innovating to find new and creative approaches to address challenges,” said Jeremy Huval, Chief Innovation Officer, HITRUST. “Strive Health’s HITRUST CSF Certification is evidence that they are at the forefront of industry best practices for information risk management and compliance.”
Strive Health provides specialized, technology-enabled care services for patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD). The company combines advanced technology with high-touch patient care to slow kidney disease progression, prevent unnecessary and costly hospitalizations, and expand access to optimal therapies such as home dialysis and transplants.
